The role of decitabine for the treatment of acute myeloid leukemia. - Wikidata - awgldk - TriplyDB

The role of decitabine for the treatment of acute myeloid leukemia.

The role of decitabine for the treatment of acute myeloid leukemia.

http://www.wikidata.org/entity/Q38056891

about

Decitabine: a review of its use in older patients with acute myeloid leukaemia.SMG1 acts as a novel potential tumor suppressor with epigenetic inactivation in acute myeloid leukemia.Concurrent chronic neutrophilic leukemia blast crisis and multiple myeloma: A case report and literature review Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis.Acute appendicitis in acute leukemia and the potential role of decitabine in the critically ill patient.Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia.Upregulation of miR-142-3p Improves Drug Sensitivity of Acute Myelogenous Leukemia through Reducing P-Glycoprotein and Repressing Autophagy by Targeting HMGB1 High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia.Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia.Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents.Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemia.

P2860

Q33407030-A6F801C7-123E-42B7-92CC-5B5B6D217E96 Q34356687-7A237528-1C01-44F5-B7D7-547F0E839BD6 Q35742255-48577A97-5282-4CF4-9BBF-D760F5BB7152 Q39096643-F47C54DB-9A46-4C5C-9EC1-2C8637B2E928 Q39476734-6789B25D-D6E5-4B36-86F8-9AC320BAAB77 Q40776347-34CDCE8E-2425-40FB-9825-F5695B8DD5BA Q42090608-03829659-7F53-4D92-B72B-E4FD2CE0E7FA Q44001281-2D394EFB-8794-46FA-86F6-0642B3A428CC Q46679788-D2791042-83CC-4D25-B929-7A9F5FF78F08 Q51743495-14418E3C-1425-4B74-8B61-37406C8C5B77 Q52883093-E2532905-5093-4373-9FC4-3B3B388BB245

P2860

The role of decitabine for the treatment of acute myeloid leukemia.

http://www.wikidata.org/entity/Q38056891

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The role of decitabine for the treatment of acute myeloid leukemia.

@en

type

label

The role of decitabine for the treatment of acute myeloid leukemia.

@en

prefLabel

The role of decitabine for the treatment of acute myeloid leukemia.

@en

P1433

Q38056891-26D3CCB5-3A5B-4848-8A0C-E472FE6202A6

P1476

Q38056891-C31F5730-3937-452C-9A8D-89BE578AE92B

P2093

Q38056891-4B067592-0DA0-4866-969D-86930FE73245

P2860

Q38056891-139BD0D3-7414-4C34-821F-4C0C889D58ED

Q38056891-29C74908-E478-44B3-96CE-1E188E76D5C2

Q38056891-2A2A6EE9-00A3-4128-A98A-12F2EC0EEFE5

Q38056891-3795366E-3C1B-4954-B2DA-E36E6BF8BF40

Q38056891-3EA5FBAF-0ED3-4DF2-9A08-ABD6633F0580

Q38056891-40772E3B-A45E-41D9-A445-23971F163FDA

Q38056891-559D72F5-C6A6-4401-A85A-D40819A618AB

Q38056891-62DB2E8C-B896-4C92-9640-8F306C1FA13A

Q38056891-6E164F1E-4991-4F4B-882B-6453E4FFBCFA

Q38056891-71E73358-B2FF-4C8F-B52B-039A357BE03B

P304

Q38056891-5E18124E-E535-4BBA-9C33-B775A4735479

P31

Q38056891-33F3CA27-8B9F-42E9-BE10-2FED2FAFCD39

P356

Q38056891-FF3A749C-9464-49FC-B9F5-732426E44ECE

P407

Q38056891-56FF7A2F-74F9-4767-A2FA-61CF655832A6

P433

Q38056891-B55256B3-553F-4733-8229-F9C4954AFAAC

P478

Q38056891-ED668921-11FB-4057-B3E4-7C11A0C478EA

P577

Q38056891-E20C8417-3E23-4CED-B99B-ED833E80D377

P698

Q38056891-F43850B2-A24A-4F6E-80FD-3347FEB2ABB0

P921

Q38056891-F1ED1224-56FC-4DD6-B4D5-371FD81BC682

P356

P1433

Annals of Pharmacotherapy

P1476

The role of decitabine for the treatment of acute myeloid leukemia.

@en

P2093

Alex Ganetsky

http://www.w3.org/2001/XMLSchema#string

P2860

Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.

Hypermethylation of gene promoters in hematological neoplasia

Feasibility of therapy with hypomethylating agents in patients with renal insufficiency

Epigenetics and human disease: translating basic biology into clinical applications

Gene silencing in cancer in association with promoter hypermethylation

Cancer epigenetics comes of age

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.

Aberrant DNA methylation as a cancer-inducing mechanism.

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

Decitabine--bedside to bench.

P304

1511-1517

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1R151

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23115225

http://www.w3.org/2001/XMLSchema#string

P921